FDA Approves the First Four-Phase Oral Contraceptive to Hit U.S. Markets

In the midst of the birth control pills 50th birthday, the FDA has officially approved a brand new birth control option for American women. The pill, Natazia, was officially given the stamp of approval by the U.S. Food and Drug Administration on Thursday. Looks like Natazia has the same risks with the potential for less menstrual bleeding. Moreover, Natazia combines the hormones estrogen and progestin in doses that adjust four-times throughout a woman’s cycle.

The pill, already licensed in Europe under the brand name Qlaira, is the first four-phase oral contraceptive marketed in the United States, the FDA said.

It delivers varying doses of the hormones progestin at four times throughout each 28-day treatment cycle.

“Nearly 12 million women in the United States and more than 100 million women worldwide currently use oral contraceptives,” said the FDA’s Dr. Scott Monroe.

“The approval of Natazia provides another option for women who choose to use an oral contraceptive as their method of contraception.”

Two studies of 1,867 women found Natazia was effective, with many of the same side effects as other birth control pills, the FDA said.

In October, Bayer reported the drug could also reduce excessive menstrual bleeding.

About aj:
Andrew (AJ) is a vehement progressive, youth activist, and reproductive justice organizer. When he's not busy with the movement, you can usually find him dancing in the club or watching trashy reality tv.

Comments

  1. freewomyn says:

    Sweet.

Speak Your Mind

*